Vitarroz Sazon Con Culantro Y Achiote Coriander & Annatto
Reason Cumin may contain undeclared peanut protein
SAZON IBERIA CON CULANTRO Y ACHIOTE Coriander & Annatto recall
Recalled by Iberia Foods Company of New York, Inc · Brooklyn, NY, United States
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Cumin may contain undeclared peanut protein
Undeclared allergen: Peanut
For someone with a food allergy the label is the only protection. An undeclared allergen can trigger a severe reaction even in a trace amount, which is why most of these recalls are Class I. All undeclared allergens recalls.
What was recalled
SAZON IBERIA CON CULANTRO Y ACHIOTE Coriander & Annatto: 1) NET WT. 3.52 OZ. 100g, 18/20 PACKS, UPC 0 75669 10832 9, 2) NET WT. 6.34 OZ. 180g, 15/36 PACKS, UPC 0 75669 10831 2
Quantity: 2,022 cases total (1494 cases 15/36, 528 cases 18/20)
Lot codes, dates and UPCs
A recall covers only these codes. Compare them with the lot number, best-by date or UPC printed on your package.
lot numbers 27012014 or 30212014
Where it was sold
Nationwide.
FDA's distribution note: Nationwide
Check the codes, then return or discard. Class II means eating it may cause temporary or reversible health problems. If your package matches the recalled codes, do not eat it - return it to the store or throw it away. The risk from an undeclared allergen is to people allergic to peanut; for anyone else the product is generally not a safety concern. FDA lists this recall as terminated: the company has finished removing the product, so it should no longer be on shelves - but it can still be in a freezer or pantry.
- Recalling firm
- Iberia Foods Company of New York, Inc
- Initiated by
- Voluntary: Firm initiated
- Recall initiated
- Feb 20, 2015
- In FDA report of
- Apr 15, 2015
- Terminated
- Mar 31, 2017
- FDA recall number
- F-1941-2015 · event 70639
- Official record
- FDA enforcement report search
Also recalled with it (1 more product)
FDA files each product of one recall action separately; these share the same FDA event.